Capex of Rs 150-180 cr earmarked for FY20: RBV Bubna, Sharda CropChem
  • WebDesk BTVI
  • Jun 04 2019

RBV Bubna, MD of Sharda CropChem, says the firm’s business is based on registration and that it puts stress on getting new products registered in different territories to make an inroad. He says the firm will continue to grow at around 20% going ahead and that he expects RoEs to be better in 2019-20. He adds that fluctuating Latin American currencies and exchange rate has impacted the firm’s growth.